Orlando Health, Inc.
Clinical trials sponsored by Orlando Health, Inc., explained in plain language.
-
Doctors challenge the 4-Week wait for pancreatitis treatment
Disease control Recruiting nowThis trial is testing whether performing a minimally invasive endoscopic drainage procedure early (within 26 days) is better than waiting about 4 weeks for patients with a severe, infected pancreatic fluid collection. It aims to see if early intervention prevents patients from ge…
Phase: NA • Sponsor: Orlando Health, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
ChatGPT as a cancer spotter? AI tested for Real-Time biopsy analysis
Diagnosis Recruiting nowThis study is testing if the AI tool ChatGPT can accurately identify abnormal or cancerous cells during a biopsy procedure for gastrointestinal masses. It will compare the AI's analysis to that of expert pathologists. The goal is to see if widely available AI could help more clin…
Sponsor: Orlando Health, Inc. • Aim: Diagnosis
Last updated Mar 18, 2026 14:40 UTC
-
Massive study launched to track outcomes of common pancreatitis procedure
Knowledge-focused Recruiting nowThis study is creating a registry to track the results of a standard endoscopic procedure used to drain painful fluid collections that can form after pancreatitis. It will follow 1,000 adult patients who are already scheduled to receive this treatment as part of their normal care…
Sponsor: Orlando Health, Inc. • Aim: Knowledge-focused
Last updated Mar 19, 2026 14:55 UTC